MC2 Therapeutics A/S
CVR number: 29526346
Agern Alle 24-26, 2970 Hørsholm
tel: 20181111
Income statement (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | -4 727.29 | -74 371.73 | 576.83 |
| Employee benefit expenses | -31 462.75 | -29 368.25 | -32 616.86 |
| Total depreciation | - 703.50 | -1 540.16 | -1 508.69 |
| EBIT | -36 893.54 | - 105 280.13 | -33 548.72 |
| Other financial income | 224.30 | 1 972.22 | 5 477.94 |
| Other financial expenses | -3 102.65 | -8 295.99 | -19 726.37 |
| Pre-tax profit | -39 771.89 | - 111 603.90 | -47 797.15 |
| Income taxes | 14 548.93 | 10 189.17 | 5 928.25 |
| Net earnings | -25 222.96 | - 101 414.73 | -41 868.90 |
Assets (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Intangible assets total | |||
| Buildings | 5 702.43 | 4 819.94 | 4 400.51 |
| Machinery and equipment | 2 774.48 | 2 232.09 | 1 781.03 |
| Tangible assets total | 8 476.91 | 7 052.03 | 6 181.54 |
| Other receivables | 271.58 | 271.58 | 444.00 |
| Investments total | 271.58 | 271.58 | 444.00 |
| Long term receivables total | |||
| Finished products/goods | 5 354.66 | 11 029.32 | 13 935.71 |
| Advance payments | 4 481.84 | ||
| Inventories total | 5 354.66 | 15 511.16 | 13 935.71 |
| Current trade debtors | 5 238.22 | 14 471.79 | 7 691.61 |
| Prepayments and accrued income | 899.13 | 13 676.36 | 5 593.40 |
| Current other receivables | 9 595.02 | 4 919.53 | 1 795.72 |
| Current deferred tax assets | 19 534.90 | 19 133.14 | 6 003.13 |
| Short term receivables total | 35 267.26 | 52 200.83 | 21 083.86 |
| Cash and bank deposits | 18 591.30 | 8 628.49 | 15 997.05 |
| Cash and cash equivalents | 18 591.30 | 8 628.49 | 15 997.05 |
| Balance sheet total (assets) | 67 961.71 | 83 664.08 | 57 642.16 |
Equity and liabilities (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 6 611.48 | 6 611.48 | 6 611.48 |
| Retained earnings | -2 486.13 | -27 846.70 | - 129 276.44 |
| Profit of the financial year | -25 222.96 | - 101 414.73 | -41 868.90 |
| Minority interest (BS) | -83.48 | - 101.30 | |
| Shareholders equity total | -21 097.61 | - 122 733.43 | - 164 635.15 |
| Non-current advances received | 3 856.87 | 8 578.82 | |
| Non-current trade creditors | 17 430.50 | ||
| Non-current owed to group member | 19 131.81 | 156 317.29 | 189 574.61 |
| Non-current deferred tax liabilities | 914.03 | 837.61 | 873.92 |
| Non-current liabilities total | 20 045.84 | 178 442.27 | 199 027.35 |
| Advances received | 503.07 | 4 425.32 | |
| Current trade creditors | 42 393.74 | 26 422.49 | 17 317.76 |
| Other non-interest bearing current liabilities | 26 619.74 | 1 029.67 | 1 506.89 |
| Current liabilities total | 69 013.48 | 27 955.23 | 23 249.97 |
| Balance sheet total (liabilities) | 67 961.71 | 83 664.08 | 57 642.16 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.